ViaDerma 

$0.000100
1
-$0.00-50%Thursday 18:03

Statistics

Day High
0.008
Day Low
0.0005
52W High
0.008
52W Low
0.0001
Volume
4,099
Avg. Volume
124,786
Mkt Cap
123,371.3
P/E Ratio
0.04
Dividend Yield
-
Dividend
-

Earnings

Mar 31Expected
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2021
-0
-0
-0
-0
Expected EPS
N/A
Actual EPS
-0.0003

Financials

-859.56%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
450,000Revenue
-3.87MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson operates in the pharmaceutical and consumer health sectors, directly competing with ViaDerma's range of medicinal and healthcare products.
Pfizer
PFE
Mkt Cap158.45B
Pfizer is a global biopharmaceutical company that develops and manufactures drugs and vaccines, including dermatological products, competing with ViaDerma.
Merck
MRK
Mkt Cap356.01B
Merck & Co., Inc. is involved in the discovery, development, manufacturing, and marketing of pharmaceuticals, including skin health products, competing with ViaDerma.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie is a biopharmaceutical company with a strong lineup of dermatology products, making it a direct competitor to ViaDerma.
GSK
GSK
Mkt Cap94.23B
GlaxoSmithKline is a global healthcare company that produces pharmaceuticals, including skin health products, competing with ViaDerma.
Novartis
NVS
Mkt Cap268B
Novartis is a global healthcare company that operates across various segments, including dermatology, making it a competitor to ViaDerma.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol-Myers Squibb is a global biopharmaceutical company with products in various therapeutic areas, including skin conditions, competing with ViaDerma.
Lilly(Eli) &
LLY
Mkt Cap1.02T
Eli Lilly and Company is a global pharmaceutical company with a focus on dermatology among other areas, competing with ViaDerma.
AMGEN
AMGN
Mkt Cap217.9B
Amgen is a biotechnology company with products that could compete in the dermatological space, making it a competitor to ViaDerma.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap46.1B
Teva Pharmaceutical Industries is a global company that manufactures generic and specialty medicines, including dermatological products, competing with ViaDerma.

About

ViaDerma, Inc., a specialty pharmaceutical enterprise based in the United States, focuses on both the development and commercialization of pharmaceutical products. It also licenses its proprietary technology to other companies within the pharmaceutical sector, addressing various therapeutic areas. The company's primary offering is Vitastem, a topical antibiotic containing tetracycline, effective for treating a broad spectrum of ailments such as cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. Beyond its established products, ViaDerma is dedicated to expanding its pipeline, with ongoing development in fields including advanced topical antibiotics, antifungal treatments for toenails, diabetic amputation recovery, general acne, psoriasis, eczema, burn care, anti-aging and wrinkle-reducing formulations, medical cannabis applications, male pattern baldness, skin cancer, erectile dysfunction, and pain management. Established in 2007, the company operated as Décor Products International, Inc. until its renaming to ViaDerma, Inc. in May 2014. Its corporate operations are directed from Marina Del Rey, California.
Show More
CEO
Christopher A Otiko
Employees
75
Country
United States
ISIN
US92555K1016

Listings

0 Comments

Share your thoughts

FAQs

What is ViaDerma stock price today?▼
The current price of VDRM is $0.00 USD — it has decreased by -50% in the past 24 hours. Watch ViaDerma stock price performance more closely on the chart.
What is ViaDerma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange ViaDerma stocks are traded under the ticker VDRM.
Is ViaDerma stock price growing?▼
VDRM stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year ViaDerma has showed a -50% decrease.
What is ViaDerma market cap?▼
Today ViaDerma has the market capitalization of 123,371.3
What were ViaDerma earnings last quarter?▼
VDRM earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is ViaDerma revenue for the last year?▼
ViaDerma revenue for the last year amounts to 450,000 USD.
What is ViaDerma net income for the last year?▼
VDRM net income for the last year is -3.87M USD.
How many employees does ViaDerma have?▼
As of November 2, 2026, the company has 75 employees.
In which sector is ViaDerma located?▼
ViaDerma operates in the Health & Wellness sector.
When did ViaDerma complete a stock split?▼
The last stock split for ViaDerma was on May 6, 2014 with a ratio of 1:50.
Where is ViaDerma headquartered?▼
ViaDerma is headquartered in Las Vegas, United States.